MRC: Infections and immunity - responsive mode research grant: Deadline 30 April 2025
About
The Infections and Immunity Board (IIB) aims to develop scientific knowledge that extends their understanding of human infectious disease and the role of the immune system in inflammation, immune-mediated disease, and cancer. This includes research into human pathogens and their mechanisms of infection, diseases of the human immune system, and conditions where altered immune regulation leads to pathology.
The board seeks to support a diverse portfolio of research that is relevant to the UK and the wider world and spans the full remit of the board, addressing established questions and areas while catalysing investigation of emergent opportunities.
Funded research includes discovery research relating to the following areas:
- human pathogens
- immune-mediated disease and multimorbidity
- immunology and inflammation
- antimicrobial resistance
- chronic Infections
- co-infection
- epidemiology and transmission
- vaccines
- biomarkers and diagnostics
- therapeutics
Duration: up to five years, typically projects last three to four years
Funding availability: No limit, needs to be appropriate to the project and justifiable in respect of the deliverables for the proposed research
Apply to the MRC: Infections and immunity - responsive mode research grant